Prosecution Insights
Last updated: October 02, 2026
Application No. 18/572,371

Secondary Securement Device for Vascular Access Device

Non-Final OA §102§103
Filed
Dec 20, 2023
Priority
Jan 03, 2023 — nonprovisional of PCTUS2023010023
Examiner
DOUBRAVA, JOHN A
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Becton, Dickinson and Company
OA Round
1 (Non-Final)
77%
Grant Probability
Favorable
1-2
OA Rounds
3m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 77% — above average
77%
Career Allowance Rate
240 granted / 312 resolved
+6.9% vs TC avg
Strong +26% interview lift
Without
With
+26.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
28 currently pending
Career history
340
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
47.1%
+7.1% vs TC avg
§102
19.9%
-20.1% vs TC avg
§112
26.9%
-13.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 312 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant's election with traverse of Group I in the reply filed on June 2, 2026 is acknowledged. The traversal is on the grounds that independent claims 1 and 13 both require a base incorporating an integrated structure on its top surface that is mechanically secure with the tubing of a vascular access device. This is not found persuasive because the above characterization generalizes the pegs of claim 1 and the securing members of claim 13 as integrated structures on the top surface of the base. Claims 1 and 13 more specifically claim pegs and securing members such that these claims lack the same or corresponding integrated structures on the top surface of the base. The requirement is still deemed proper and is therefore made FINAL. Claims 13-20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected Group II, there being no allowable generic or linking claim. Applicant timely traversed the restriction (election) requirement in the reply filed on June 2, 2026. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-8 and 10-11 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Payton et al. (Payton) US 4,742,824. Regarding claim 1, Payton discloses a secondary securement device (patch 10, c 3 ln 1) for a vascular access device (this is being interpreted as merely an intended use that does not result in a structural difference between the claimed invention and the prior art, see MPEP 2111.02) comprising tubing (oxygen tube 30, c 3 ln 15), the secondary securement device comprising: a base (front petal 12, back petal 14 and bottom petal 15, c 3 ln 2-3) including a first end, a second end positioned opposite the first end, a first side, a second side positioned opposite the first side, a top surface, and a bottom surface positioned opposite the top surface, the bottom surface configured to be in contact with a patient's skin surface (see annotated Figs. 1 and 5 below); and a plurality of pegs (posts 22 and 24, c 3 ln 9-11) connected to the base and extending from the top surface of the base, wherein adjacent pegs of the plurality of pegs are configured to secure the tubing of the vascular access device (Fig. 4). PNG media_image1.png 666 879 media_image1.png Greyscale Regarding claim 2, Payton discloses the secondary securement device of claim 1, wherein the plurality of pegs are arranged into rows and columns (see annotated Fig. 2 above). Regarding claim 3, Payton discloses the secondary securement device of claim 2, wherein each of the plurality of pegs is engaged with at least one other of the plurality of pegs (see Figs. 1 and 3-4 showing each of the plurality of pegs engaged with at least one other of the plurality of pegs in securing tube 30). Regarding claim 4, Payton discloses the secondary securement device of claim 1, wherein at least a portion of the plurality of pegs are arranged in pairs (see annotated Fig. 4 above). Regarding claim 5, Payton discloses the secondary securement device of claim 4, wherein the plurality of pegs are spaced from each other (Fig. 2). Regarding claim 6, Payton discloses the secondary securement device of claim 1, wherein each of the plurality of pegs comprises a connecting portion (bodies 25, c 3 ln 13) connected to the base and a head portion (heads 26, c 3 ln 13-14) extending from the connecting portion (Fig. 5). Regarding claim 7, Payton discloses the secondary securement device of claim 6, wherein the head portion is semi-spherical (Fig. 5). Regarding claim 8, Payton discloses the secondary securement device of claim 6, wherein the head portion is spherical (Fig. 2). Regarding claim 10, Payton discloses the secondary securement device of claim 1, further comprising first (post 44, c 3 ln 48) and second anchors (adhesive, c 2 ln 66) configured to be secured to the tubing of the vascular access device (Fig. 1). Regarding claim 11, Payton discloses the secondary securement device of claim 1, wherein the plurality of pegs comprise an elastomeric material (patch 10 is formed of medical grade vinyl, c 2 ln 65, and see Payton 4,66,555 c 4 ln 1-3 that teaches vinyl as an elastomeric material). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim 9 is rejected under 35 U.S.C. 103 as being unpatentable over Payton in view of McConnel US 4,029,103. Regarding claim 9, Payton discloses the secondary securement device of claim 6. Payton does not teach the secondary securement device wherein the connecting portion of each peg comprises a recessed area configured to receive a portion of the tubing of the vascular access device. However, McConnel teaches an anchoring plate for medical tubes wherein the connecting portion comprises a recessed area (internal curved passageway 13, c 3 ln 27) configured to receive a portion of the tubing of the vascular access device (Fig. 5). It would have been obvious to one having ordinary skill in the art before the effective filing date of the invention to modify the bodies 25 of Payton with a recessed area as taught by McConnel for the purpose of forming an interference fit with the medical tubing to immobilize the medical tubing contained therein, McConnel c 3 ln 30-32. Claim 12 is rejected under 35 U.S.C. 103 as being unpatentable over Payton in view of Bierman US 6,979,320 B2. Regarding claim 12, Payton discloses the secondary securement device of claim 1, wherein the bottom surface of the base comprises an adhesive surface (adhesive, c 2 ln 66). Payton does not explicitly teach a liner for the adhesive surface. However, Bierman teaches an anchoring system wherein the adhesive surface 58 is provided with a liner 68, c 8 ln 35. It would have been obvious to one having ordinary skill in the art before the effective filing date of the invention to modify the adhesive surface of Payton with a liner as taught by Bierman for the purpose of covering the adhesive surface before use, Payton c 8 ln 35-37. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOHN A DOUBRAVA whose telephone number is (408)918-7561. The examiner can normally be reached M-F 9-5 Pacific Time. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bhisma Mehta can be reached at 571-272-3383. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /J.A.D./Examiner, Art Unit 3783 /James D Ponton/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Dec 20, 2023
Application Filed
Aug 11, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12741088
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION CATHETER
8y 6m to grant Granted Sep 22, 2026
Patent 12702757
MULTI-CHAMBER SYRINGE
3y 7m to grant Granted Aug 11, 2026
Patent 12697429
DEVICES AND METHODS FOR CLEANING CONTAMINATED BODY CAVITIES
3y 5m to grant Granted Aug 04, 2026
Patent 12685825
Sealed Multi Chamber Syringe for Storage, Mixing and Delivery of Multi Part Substances
4y 0m to grant Granted Jul 21, 2026
Patent 12672887
CLOT REMOVAL SYSTEM AND METHODS OF USE
4y 6m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
77%
Grant Probability
99%
With Interview (+26.4%)
3y 1m (~3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 312 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month